PharmaShots | Incisive News in 3 Shots

Subscribe Now

pressroom

Shire's Takhzyro IV (lanadelumab) Receives EU's Approval for Hereditary Angioedema

Shire's Takhzyro IV (lanadelumab) Receives EU's Approval for Hereditary Angioedema

December 3, 2018

Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to < 24 Months

Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to < 24 Months

November 30, 2018

NTU SingaporeTTSH Develops AI based Smart Medical Device for Early Detection of Congestive Heart Failure

NTU SingaporeTTSH Develops AI based Smart Medical Device for Early Detection of Congestive Heart Failure

November 30, 2018

Novartis' Gilenya (fingolimod) Receives EU's Approval for Relapsing-Remitting Forms of Multiple Sclerosis (RRMS)

Novartis' Gilenya (fingolimod) Receives EU's Approval for Relapsing-Remitting Forms of Multiple Sclerosis (RRMS)

November 30, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us